Skip to content

Heat Wrap Device Safety With Age and Body Fat

AN OPEN LABEL STUDY TO COMPARE THE EFFECTS OF AGE AND BODY FAT ON THE SAFETY OF TWO HEAT WRAP DEVICES IN HEALTHY SUBJECTS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01355653
Enrollment
45
Registered
2011-05-18
Start date
2011-05-05
Completion date
2011-07-28
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain

Keywords

heat, device, safety, performance, heatwrap, elderly, overweight

Brief summary

This study is designed to compare the safety, as measured by skin findings and adverse events, of two different heat devices in elderly, overweight, and elderly and overweight subjects.

Detailed description

Safety measurements

Interventions

heat therapy device, topical, two applications, at 0-3 hours and 4-6 hours on treatment day

DEVICEThermaCare heatwrap

heatwrap, topical, one time application, 8 hour duration

Sponsors

Pfizer
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 84 Years
Healthy volunteers
Yes

Inclusion criteria

* Males or females in generally good health, and who are either 18-54 years of age with a body mass index of ≥ 30 kg/m2 * or 55-84 years of age and with a body mass index ≥ 30 kg/m2 or \< 30 kg/m2 * Females who are not pregnant or breastfeeding * Subject is medically cleared for study participation

Exclusion criteria

* No sensitivitiy or allergy to device components in contact with skin * Diabetes * Any active skin disease or tattoos at the test site that would affect participation

Design outcomes

Primary

MeasureTime frame
Percentage of subjects with any thermal-related skin events (defined as elevated skin response, erythema ≥ 2.0 [moderate], or pain upon touch plus non-zero erythema)morning after product wear through 15 days after last product application

Secondary

MeasureTime frame
Percentage of subjects with any adverse eventduring and after wear for 28 days after last wear

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026